Drug Shortage Report for TARO-TESTOSTERONE CYPIONATE INJECTION
Report ID | 173707 |
Drug Identification Number | 02496003 |
Brand name | TARO-TESTOSTERONE CYPIONATE INJECTION |
Common or Proper name | TESTOSTERONE |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | TESTOSTERONE CYPIONATE |
Strength(s) | 100MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR |
Packaging size | 10 |
ATC code | G03BA |
ATC description | ANDROGENS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-10-27 |
Estimated end date | 2023-02-24 |
Actual end date | 2023-02-24 |
Shortage status | Resolved |
Updated date | 2023-02-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v18 | 2023-02-28 | French | Compare |
v17 | 2023-02-28 | English | Compare |
v16 | 2023-02-01 | French | Compare |
v15 | 2023-02-01 | English | Compare |
v14 | 2023-02-01 | French | Compare |
v13 | 2023-02-01 | English | Compare |
v12 | 2023-01-19 | French | Compare |
v11 | 2023-01-19 | English | Compare |
v10 | 2023-01-10 | French | Compare |
v9 | 2023-01-10 | English | Compare |
v8 | 2022-12-12 | French | Compare |
v7 | 2022-12-12 | English | Compare |
v6 | 2022-11-24 | French | Compare |
v5 | 2022-11-24 | English | Compare |
v4 | 2022-11-15 | French | Compare |
v3 | 2022-11-15 | English | Compare |
v2 | 2022-11-04 | French | Compare |
v1 | 2022-11-04 | English | Compare |
Showing 1 to 18 of 18